Ferroptosis-centered Disease Response Information
General Information of the Disease (ID: DIS00051)
Name |
Hemangioma
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 2E81
|
Full List of Target(s) of This Ferroptosis-centered Disease
Cystine/glutamate transporter (SLC7A11)
In total 3 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
Responsed Regulator | hsa-miR-497-5p (miRNA) | Driver | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Notch signaling pathway | hsa04330 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||
Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
Responsed Regulator | Neurogenic locus notch homolog protein 2 (NOTCH2) | Suppressor | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Notch signaling pathway | hsa04330 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/ NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||
Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
Responsed Regulator | MEG8 (IncRNA) | Suppressor | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Notch signaling pathway | hsa04330 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||